Luminespib
Luminespib (INN,[1] previously known as NVP-AUY922) is an experimental drug candidate for the treatment of cancer. It was discovered through a collaboration between The Institute of Cancer Research and the pharmaceutical company Vernalis[2] and licensed to Novartis.[3] From 2011 to 2014 it was in Phase II clinical trials.[4][5] Chemically it is a resorcinylic isoxazole amide[5]
Luminespib is an inhibitor of heat shock protein 90 (Hsp90),[6] which is a chaperone protein that plays a role in the modification of a variety of proteins that have been implicated in oncogenesis. Luminespib has shown promising activity in preclinical testing against several different tumor types.[7][8][9][10]
A related compound, NVP-HSP990, was abandoned by Novartis in 2012 after it failed to show efficacy in an early clinical trial.[5]
See also[edit | edit source]
References[edit | edit source]
- ↑ "WHO Drug Information. International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 70" (PDF). World Health Organization. pp. 297–8. Retrieved 16 July 2016.
- ↑ "Structure-based design of cancer therapeutics" (PDF). The Institute of Cancer Research.
- ↑ "AUY922". Vernalis. Archived from the original on 2011-09-29.
{{cite web}}
: Unknown parameter|deadurl=
ignored (help) - ↑ "Small caps: Vernalis drug fillip". Financial Times. July 19, 2011.
{{cite web}}
: Italic or bold markup not allowed in:|publisher=
(help) - ↑ 5.0 5.1 5.2
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedBrough
- ↑
- ↑
- ↑
- ↑
Luminespib Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD